-+ 0.00%
-+ 0.00%
-+ 0.00%

Catalyst Pharmaceuticals Affirms FY2025 Sales Guidance of $545.00M-$565.00M vs $557.24M Est

Benzinga·05/07/2025 20:50:43
Listen to the news
Catalyst Pharmaceuticals (NASDAQ:CPRX) affirms FY2025 sales outlook from $545.00 million-$565.00 million to $545.00 million-$565.00 million vs $557.24 million estimate.